Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Versus Late Stopping of Antibiotics in Adults With High Risk Haematological Malignancies/Receiving Cellular Therapies and Fever (ELSA- Adult)

NCT07051525 is registered in ClinicalTrials.gov with Peter MacCallum Cancer Centre, Australia as lead sponsor.

NCT NCT07051525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07051525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Versus Late Stopping of Antibiotics in Adults With High Risk Haematological Malignancies/Receiving Cellular Therapies and Fever (ELSA- Adult)
Lead sponsor
Peter MacCallum Cancer Centre, Australia
Phase
Not applicable
Overall status
Recruiting
Start date
December 3, 2025
Completion date
February 5, 2028
Enrollment
214 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cart therapy, infections, bacterial, leukemia, transplantation, stem cell